Narita, Koichi
Amiya, Eisuke
Hatano, Masaru
Ishida, Junichi
Maki, Hisataka
Minatsuki, Shun
Tsuji, Masaki
Saito, Akihito
Bujo, Chie
Ishii, Satoshi
Kakuda, Nobutaka
Shimbo, Mai
Hosoya, Yumiko
Endo, Miyoko
Kagami, Yukie
Imai, Hiroko
Itoda, Yoshifumi
Ando, Masahiko
Shimada, Shogo
Kinoshita, Osamu
Ono, Minoru
Komuro, Issei
Funding for this research was provided by:
the Ministry of Education, Culture, Sports, Science and Technology of Japan through Grant-in-Aid (17K09488)
Article History
Received: 22 July 2020
Accepted: 17 November 2020
First Online: 3 December 2020
Competing interests
: EA and MH belong to the Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo, which is endowed by Actelion Pharmaceuticals Japan Ltd., Otsuka Pharmaceutical, NIPRO CORPORATION, Terumo Corp., Senko Medical Instrument Mfg., Century Medical Inc., Kinetic Concepts Inc., and St. Jude Medical. The other authors have no conflicts of interest to disclose. There are no patents, products in development, or marketed products to declare.